NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOSL1
|
ENSG00000175592.4 | FOS like 1, AP-1 transcription factor subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL1 | hg19_v2_chr11_-_65667997_65668044 | 0.96 | 1.9e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153013588 | 3.91 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr7_+_22766766 | 3.54 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr1_-_153066998 | 2.78 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr4_+_74606223 | 2.69 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr20_+_44637526 | 2.40 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr12_-_58159361 | 1.97 |
ENST00000546567.1
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1 |
chr1_-_153029980 | 1.90 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr6_+_138188551 | 1.87 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr6_+_138188351 | 1.78 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr5_+_147582348 | 1.76 |
ENST00000514389.1
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6 |
chr3_+_14474178 | 1.65 |
ENST00000452775.1
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6 |
chr6_+_138188378 | 1.63 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr1_+_152956549 | 1.54 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
chr2_-_241835561 | 1.43 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr17_-_42994283 | 1.31 |
ENST00000593179.1
|
GFAP
|
glial fibrillary acidic protein |
chr1_+_152881014 | 1.31 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr19_-_6670128 | 1.29 |
ENST00000245912.3
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14 |
chr10_+_104155450 | 1.08 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr1_+_153003671 | 1.06 |
ENST00000307098.4
|
SPRR1B
|
small proline-rich protein 1B |
chr15_+_89182178 | 1.06 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr12_+_56732658 | 1.05 |
ENST00000228534.4
|
IL23A
|
interleukin 23, alpha subunit p19 |
chr18_+_61554932 | 1.03 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr6_-_30685214 | 1.02 |
ENST00000425072.1
|
MDC1
|
mediator of DNA-damage checkpoint 1 |
chr14_-_75083313 | 1.00 |
ENST00000556652.1
ENST00000555313.1 |
CTD-2207P18.2
|
CTD-2207P18.2 |
chr22_-_30642728 | 0.97 |
ENST00000403987.3
|
LIF
|
leukemia inhibitory factor |
chr11_+_28724129 | 0.93 |
ENST00000513853.1
|
RP11-115J23.1
|
RP11-115J23.1 |
chr11_-_102826434 | 0.92 |
ENST00000340273.4
ENST00000260302.3 |
MMP13
|
matrix metallopeptidase 13 (collagenase 3) |
chr17_-_39769005 | 0.91 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr11_-_102668879 | 0.91 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr14_-_51863853 | 0.90 |
ENST00000556762.1
|
RP11-255G12.3
|
RP11-255G12.3 |
chr7_+_73245193 | 0.90 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
chr15_+_89182156 | 0.88 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr22_-_30642782 | 0.86 |
ENST00000249075.3
|
LIF
|
leukemia inhibitory factor |
chr1_-_95007193 | 0.85 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr10_+_30723105 | 0.81 |
ENST00000375322.2
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr22_+_37959647 | 0.80 |
ENST00000415670.1
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1 |
chr10_+_30723045 | 0.79 |
ENST00000542547.1
ENST00000415139.1 |
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr5_+_35856951 | 0.78 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr2_+_27505260 | 0.77 |
ENST00000380075.2
ENST00000296098.4 |
TRIM54
|
tripartite motif containing 54 |
chr10_+_30722866 | 0.75 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr6_+_106546808 | 0.74 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr4_+_84457250 | 0.74 |
ENST00000395226.2
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr16_+_89988259 | 0.73 |
ENST00000554444.1
ENST00000556565.1 |
TUBB3
|
Tubulin beta-3 chain |
chr11_-_65667884 | 0.73 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr2_+_152214098 | 0.72 |
ENST00000243347.3
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6 |
chr19_-_51538148 | 0.71 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
chr17_+_74261413 | 0.71 |
ENST00000587913.1
|
UBALD2
|
UBA-like domain containing 2 |
chr16_+_30077055 | 0.71 |
ENST00000564595.2
ENST00000569798.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr12_+_48152774 | 0.70 |
ENST00000549243.1
|
SLC48A1
|
solute carrier family 48 (heme transporter), member 1 |
chr11_-_65667997 | 0.69 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr16_+_30751953 | 0.68 |
ENST00000483578.1
|
RP11-2C24.4
|
RP11-2C24.4 |
chr4_+_84457529 | 0.68 |
ENST00000264409.4
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr2_+_162165038 | 0.68 |
ENST00000437630.1
|
PSMD14
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
chr12_-_122238464 | 0.66 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
chr16_+_67312049 | 0.65 |
ENST00000565899.1
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4 |
chr11_-_8739383 | 0.65 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chr5_+_147582387 | 0.62 |
ENST00000325630.2
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6 |
chr17_+_21191341 | 0.60 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr5_+_177540444 | 0.58 |
ENST00000274605.5
|
N4BP3
|
NEDD4 binding protein 3 |
chr6_-_44233361 | 0.57 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chrX_-_48937684 | 0.56 |
ENST00000465382.1
ENST00000423215.2 |
WDR45
|
WD repeat domain 45 |
chr1_-_113247543 | 0.56 |
ENST00000414971.1
ENST00000534717.1 |
RHOC
|
ras homolog family member C |
chr12_+_13349711 | 0.54 |
ENST00000538364.1
ENST00000396301.3 |
EMP1
|
epithelial membrane protein 1 |
chr9_+_140135665 | 0.54 |
ENST00000340384.4
|
TUBB4B
|
tubulin, beta 4B class IVb |
chr9_-_127177703 | 0.53 |
ENST00000259457.3
ENST00000536392.1 ENST00000441097.1 |
PSMB7
|
proteasome (prosome, macropain) subunit, beta type, 7 |
chr16_+_30077098 | 0.52 |
ENST00000395240.3
ENST00000566846.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr8_-_82395461 | 0.52 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
chr12_-_48152853 | 0.52 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr2_-_220117867 | 0.51 |
ENST00000456818.1
ENST00000447205.1 |
TUBA4A
|
tubulin, alpha 4a |
chr9_-_35112376 | 0.50 |
ENST00000488109.2
|
FAM214B
|
family with sequence similarity 214, member B |
chr17_-_39780819 | 0.49 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
chr8_+_126442563 | 0.48 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr17_-_18908040 | 0.48 |
ENST00000388995.6
|
FAM83G
|
family with sequence similarity 83, member G |
chr17_+_9745786 | 0.48 |
ENST00000304773.5
|
GLP2R
|
glucagon-like peptide 2 receptor |
chr4_+_76481258 | 0.47 |
ENST00000311623.4
ENST00000435974.2 |
C4orf26
|
chromosome 4 open reading frame 26 |
chr1_+_183155373 | 0.46 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
chr12_+_10365082 | 0.46 |
ENST00000545859.1
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr12_-_54813229 | 0.45 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr16_+_2083265 | 0.45 |
ENST00000565855.1
ENST00000566198.1 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
chr19_+_50706866 | 0.44 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr10_-_4285835 | 0.43 |
ENST00000454470.1
|
LINC00702
|
long intergenic non-protein coding RNA 702 |
chr13_+_78109804 | 0.43 |
ENST00000535157.1
|
SCEL
|
sciellin |
chr19_-_6057282 | 0.42 |
ENST00000592281.1
|
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr9_+_140119618 | 0.42 |
ENST00000359069.2
|
C9orf169
|
chromosome 9 open reading frame 169 |
chr19_-_51523412 | 0.42 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
chr19_-_51538118 | 0.42 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
chr9_-_35111570 | 0.41 |
ENST00000378561.1
ENST00000603301.1 |
FAM214B
|
family with sequence similarity 214, member B |
chr17_-_73781567 | 0.41 |
ENST00000586607.1
|
H3F3B
|
H3 histone, family 3B (H3.3B) |
chr12_+_7023735 | 0.41 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr1_+_36621174 | 0.41 |
ENST00000429533.2
|
MAP7D1
|
MAP7 domain containing 1 |
chr9_+_131902346 | 0.41 |
ENST00000432124.1
ENST00000435305.1 |
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4 |
chr3_+_30648066 | 0.40 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr17_-_39781054 | 0.40 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
chr10_-_106240032 | 0.40 |
ENST00000447860.1
|
RP11-127O4.3
|
RP11-127O4.3 |
chr20_+_48429356 | 0.40 |
ENST00000361573.2
ENST00000541138.1 ENST00000539601.1 |
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 |
chr16_-_66968265 | 0.40 |
ENST00000567511.1
ENST00000422424.2 |
FAM96B
|
family with sequence similarity 96, member B |
chr17_+_65375082 | 0.40 |
ENST00000584471.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr19_-_51523275 | 0.40 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr6_-_161695042 | 0.40 |
ENST00000366908.5
ENST00000366911.5 ENST00000366905.3 |
AGPAT4
|
1-acylglycerol-3-phosphate O-acyltransferase 4 |
chr14_+_94492674 | 0.39 |
ENST00000203664.5
ENST00000553723.1 |
OTUB2
|
OTU domain, ubiquitin aldehyde binding 2 |
chr11_-_9025541 | 0.39 |
ENST00000525100.1
ENST00000309166.3 ENST00000531090.1 |
NRIP3
|
nuclear receptor interacting protein 3 |
chr5_-_141061777 | 0.39 |
ENST00000239440.4
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr17_-_79481666 | 0.39 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
chr10_-_90611566 | 0.39 |
ENST00000371930.4
|
ANKRD22
|
ankyrin repeat domain 22 |
chr17_+_7255208 | 0.39 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr9_+_34992846 | 0.39 |
ENST00000443266.1
|
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr19_+_35645618 | 0.39 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr11_-_102401469 | 0.38 |
ENST00000260227.4
|
MMP7
|
matrix metallopeptidase 7 (matrilysin, uterine) |
chr10_+_75668916 | 0.38 |
ENST00000481390.1
|
PLAU
|
plasminogen activator, urokinase |
chr1_+_36621529 | 0.38 |
ENST00000316156.4
|
MAP7D1
|
MAP7 domain containing 1 |
chr1_-_28520447 | 0.38 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
chr11_+_128563652 | 0.38 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr20_-_62129163 | 0.38 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr11_-_10920714 | 0.38 |
ENST00000533941.1
|
CTD-2003C8.2
|
CTD-2003C8.2 |
chr5_+_35852797 | 0.38 |
ENST00000508941.1
|
IL7R
|
interleukin 7 receptor |
chr6_+_106534192 | 0.37 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr5_+_38148582 | 0.37 |
ENST00000508853.1
|
CTD-2207A17.1
|
CTD-2207A17.1 |
chr11_+_12308447 | 0.37 |
ENST00000256186.2
|
MICALCL
|
MICAL C-terminal like |
chr12_+_7023491 | 0.37 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr9_-_130341268 | 0.37 |
ENST00000373314.3
|
FAM129B
|
family with sequence similarity 129, member B |
chr1_+_36621697 | 0.37 |
ENST00000373150.4
ENST00000373151.2 |
MAP7D1
|
MAP7 domain containing 1 |
chrX_-_19689106 | 0.37 |
ENST00000379716.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr11_+_73000449 | 0.36 |
ENST00000535931.1
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr2_+_135596180 | 0.36 |
ENST00000283054.4
ENST00000392928.1 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chrX_-_48937503 | 0.36 |
ENST00000322995.8
|
WDR45
|
WD repeat domain 45 |
chr15_-_72521017 | 0.36 |
ENST00000561609.1
|
PKM
|
pyruvate kinase, muscle |
chr8_-_95220775 | 0.35 |
ENST00000441892.2
ENST00000521491.1 ENST00000027335.3 |
CDH17
|
cadherin 17, LI cadherin (liver-intestine) |
chr7_+_150065278 | 0.35 |
ENST00000519397.1
ENST00000479668.1 ENST00000540729.1 |
REPIN1
|
replication initiator 1 |
chr9_-_35111420 | 0.35 |
ENST00000378557.1
|
FAM214B
|
family with sequence similarity 214, member B |
chr12_-_91573249 | 0.35 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr10_-_47181681 | 0.35 |
ENST00000452267.1
|
FAM25B
|
family with sequence similarity 25, member B |
chr2_+_202122826 | 0.35 |
ENST00000413726.1
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr16_-_74330612 | 0.35 |
ENST00000569389.1
ENST00000562888.1 |
AC009120.4
|
AC009120.4 |
chr16_-_2908155 | 0.34 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
chr6_-_161695074 | 0.34 |
ENST00000457520.2
ENST00000366906.5 ENST00000320285.4 |
AGPAT4
|
1-acylglycerol-3-phosphate O-acyltransferase 4 |
chr19_+_50431959 | 0.34 |
ENST00000595125.1
|
ATF5
|
activating transcription factor 5 |
chr19_+_35645817 | 0.34 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr11_-_2950642 | 0.34 |
ENST00000314222.4
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2 |
chr14_-_94854926 | 0.33 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr12_-_48152611 | 0.33 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr11_+_10476851 | 0.33 |
ENST00000396553.2
|
AMPD3
|
adenosine monophosphate deaminase 3 |
chr4_-_122085469 | 0.33 |
ENST00000057513.3
|
TNIP3
|
TNFAIP3 interacting protein 3 |
chr19_-_18385221 | 0.33 |
ENST00000595654.2
ENST00000593659.1 ENST00000599528.1 |
KIAA1683
|
KIAA1683 |
chr7_-_130597935 | 0.33 |
ENST00000447307.1
ENST00000418546.1 |
MIR29B1
|
microRNA 29a |
chr5_-_90610200 | 0.33 |
ENST00000511918.1
ENST00000513626.1 ENST00000607854.1 |
LUCAT1
RP11-213H15.4
|
lung cancer associated transcript 1 (non-protein coding) RP11-213H15.4 |
chr1_+_150480551 | 0.32 |
ENST00000369049.4
ENST00000369047.4 |
ECM1
|
extracellular matrix protein 1 |
chr10_-_6019552 | 0.32 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr1_-_155947951 | 0.32 |
ENST00000313695.7
ENST00000497907.1 |
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
chr1_-_45272951 | 0.32 |
ENST00000372200.1
|
TCTEX1D4
|
Tctex1 domain containing 4 |
chr2_+_113875466 | 0.31 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
chr2_-_18770802 | 0.31 |
ENST00000416783.1
|
NT5C1B
|
5'-nucleotidase, cytosolic IB |
chr3_-_51937331 | 0.31 |
ENST00000310914.5
|
IQCF1
|
IQ motif containing F1 |
chr16_+_58533951 | 0.31 |
ENST00000566192.1
ENST00000565088.1 ENST00000568640.1 ENST00000563978.1 ENST00000569923.1 ENST00000356752.4 ENST00000563799.1 ENST00000562999.1 ENST00000570248.1 ENST00000562731.1 ENST00000568424.1 |
NDRG4
|
NDRG family member 4 |
chr14_-_64970494 | 0.31 |
ENST00000608382.1
|
ZBTB25
|
zinc finger and BTB domain containing 25 |
chr2_-_224467002 | 0.31 |
ENST00000421386.1
ENST00000433889.1 |
SCG2
|
secretogranin II |
chr10_+_30723533 | 0.31 |
ENST00000413724.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr10_+_48247669 | 0.31 |
ENST00000457620.1
|
FAM25G
|
family with sequence similarity 25, member G |
chr2_+_220495800 | 0.31 |
ENST00000413743.1
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr1_+_27189631 | 0.31 |
ENST00000339276.4
|
SFN
|
stratifin |
chr17_-_39780634 | 0.31 |
ENST00000577817.2
|
KRT17
|
keratin 17 |
chr5_+_150020240 | 0.30 |
ENST00000519664.1
|
SYNPO
|
synaptopodin |
chr3_+_184016986 | 0.30 |
ENST00000417952.1
|
PSMD2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
chr1_+_27719148 | 0.30 |
ENST00000374024.3
|
GPR3
|
G protein-coupled receptor 3 |
chr15_+_41062159 | 0.30 |
ENST00000344320.6
|
C15orf62
|
chromosome 15 open reading frame 62 |
chr5_+_145317356 | 0.30 |
ENST00000511217.1
|
SH3RF2
|
SH3 domain containing ring finger 2 |
chr19_-_19739321 | 0.30 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chr12_-_719573 | 0.30 |
ENST00000397265.3
|
NINJ2
|
ninjurin 2 |
chr1_+_169077133 | 0.30 |
ENST00000494797.1
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr5_-_75919253 | 0.29 |
ENST00000296641.4
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2 |
chr14_+_71108460 | 0.29 |
ENST00000256367.2
|
TTC9
|
tetratricopeptide repeat domain 9 |
chr1_-_109968973 | 0.29 |
ENST00000271308.4
ENST00000538610.1 |
PSMA5
|
proteasome (prosome, macropain) subunit, alpha type, 5 |
chr10_-_81708854 | 0.29 |
ENST00000372292.3
|
SFTPD
|
surfactant protein D |
chr11_-_67141640 | 0.29 |
ENST00000533438.1
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
chr6_-_149806105 | 0.29 |
ENST00000389942.5
ENST00000416573.2 ENST00000542614.1 ENST00000409806.3 |
ZC3H12D
|
zinc finger CCCH-type containing 12D |
chr16_-_66968055 | 0.29 |
ENST00000568572.1
|
FAM96B
|
family with sequence similarity 96, member B |
chr9_-_91793675 | 0.29 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr16_+_56782118 | 0.29 |
ENST00000566678.1
|
NUP93
|
nucleoporin 93kDa |
chr15_-_83316254 | 0.29 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr1_-_154943212 | 0.29 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr8_+_22844913 | 0.29 |
ENST00000519685.1
|
RHOBTB2
|
Rho-related BTB domain containing 2 |
chr7_+_102191679 | 0.29 |
ENST00000507918.1
ENST00000432940.1 |
SPDYE2
|
speedy/RINGO cell cycle regulator family member E2 |
chr16_-_31161380 | 0.29 |
ENST00000569305.1
ENST00000418068.2 ENST00000268281.4 |
PRSS36
|
protease, serine, 36 |
chr11_-_8739566 | 0.29 |
ENST00000533020.1
|
ST5
|
suppression of tumorigenicity 5 |
chr14_-_64971288 | 0.28 |
ENST00000394715.1
|
ZBTB25
|
zinc finger and BTB domain containing 25 |
chr17_+_26369865 | 0.28 |
ENST00000582037.1
|
NLK
|
nemo-like kinase |
chr18_+_61637159 | 0.28 |
ENST00000397985.2
ENST00000353706.2 ENST00000542677.1 ENST00000397988.3 ENST00000448851.1 |
SERPINB8
|
serpin peptidase inhibitor, clade B (ovalbumin), member 8 |
chr21_-_35340759 | 0.28 |
ENST00000607953.1
|
AP000569.9
|
AP000569.9 |
chrX_-_153718953 | 0.28 |
ENST00000369649.4
ENST00000393586.1 |
SLC10A3
|
solute carrier family 10, member 3 |
chr1_+_89990378 | 0.28 |
ENST00000449440.1
|
LRRC8B
|
leucine rich repeat containing 8 family, member B |
chr18_+_32556892 | 0.28 |
ENST00000591734.1
ENST00000413393.1 ENST00000589180.1 ENST00000587359.1 |
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2 |
chr3_+_30647994 | 0.27 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr18_+_55888767 | 0.27 |
ENST00000431212.2
ENST00000586268.1 ENST00000587190.1 |
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr17_-_1029052 | 0.27 |
ENST00000574437.1
|
ABR
|
active BCR-related |
chr1_+_150480576 | 0.26 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
chr2_-_218766698 | 0.26 |
ENST00000439083.1
|
TNS1
|
tensin 1 |
chr11_+_82783097 | 0.26 |
ENST00000501011.2
ENST00000527627.1 ENST00000526795.1 ENST00000533528.1 ENST00000533708.1 ENST00000534499.1 |
RAB30-AS1
|
RAB30 antisense RNA 1 (head to head) |
chr14_+_69726864 | 0.26 |
ENST00000448469.3
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr8_-_56987057 | 0.26 |
ENST00000518875.1
|
RPS20
|
ribosomal protein S20 |
chr18_-_68004529 | 0.26 |
ENST00000578633.1
|
RP11-484N16.1
|
RP11-484N16.1 |
chr1_-_1009683 | 0.26 |
ENST00000453464.2
|
RNF223
|
ring finger protein 223 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
0.9 | 3.5 | GO:0002384 | hepatic immune response(GO:0002384) response to prolactin(GO:1990637) |
0.7 | 2.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 2.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 1.1 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.4 | 1.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.3 | 1.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.3 | 2.4 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 1.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 1.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.2 | 0.7 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.2 | 0.6 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 1.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.9 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.2 | 11.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 0.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.1 | 0.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.1 | 0.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.4 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.3 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.1 | 0.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 1.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.5 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.6 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.3 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.1 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.4 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 1.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.0 | 0.2 | GO:0032796 | uropod organization(GO:0032796) |
0.0 | 0.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 1.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.3 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.0 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.0 | 0.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 1.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.0 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 0.4 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.6 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) amygdala development(GO:0021764) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 1.5 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.3 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 0.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 12.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.3 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.1 | 0.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 4.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 3.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.1 | GO:0044753 | amphisome(GO:0044753) |
0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.6 | 1.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 4.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 1.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.4 | 3.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 5.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 0.3 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.1 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.1 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.5 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) sulfonylurea receptor binding(GO:0017098) pyrimidine ribonucleoside binding(GO:0032551) |
0.1 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 2.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.1 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.4 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 2.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 8.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 2.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 3.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.0 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 15.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 6.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 4.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 5.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 2.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 2.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 2.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 2.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 2.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |